# Rule of Carbone Monoxyde in the Ex Vivo Lung Perfusion Reconditionning

> **NCT02032082** · NA · UNKNOWN · sponsor: **University Hospital of Mont-Godinne** · enrollment: 40 (actual)

## Conditions studied

- Neurogenic Lung Edema

## Interventions

- **OTHER:** Carbone monoxide

## Key facts

- **NCT ID:** NCT02032082
- **Lead sponsor:** University Hospital of Mont-Godinne
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-01
- **Primary completion:** 2018-01
- **Final completion:** 2018-01
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2016-03-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02032082

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02032082, "Rule of Carbone Monoxyde in the Ex Vivo Lung Perfusion Reconditionning". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02032082. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*